Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Swemac is a Swedish medical technology company specializing in the development and manufacture of orthopedic implants and instruments for fracture treatment and joint reconstruction. Founded in 1982 and based in Linköping, the company is globally recognized for its Hansson Pin System, a gold standard for the internal fixation of femoral neck fractures. Swemac's product portfolio also includes advanced solutions for the wrist, ankle, and shoulder, designed to provide biomechanical stability and simplify surgical workflows. In 2016, Swemac was acquired by the Swiss orthopedic specialist Medartis, which integrated Swemac's trauma and extremities expertise into its global operations. Today, the company continues to innovate within the Medartis group, focusing on high-quality Swedish engineering to improve patient recovery in orthopedic surgery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Swemac Orthopaedics.